Search
for
Sort by
Research 211–240 of 1000+
- Hormone Blocking Anticancer Drugs
- PERAN KELENJAR SEBASEA PADA ALOPESIA ANDROGENIK
- The challenging role of antiandrogens in the management of polycystic ovary syndrome
- Corrections to “Female Pattern Hair Loss and its Relationship to Permanent/Cicatricial Alopecia: A New Perspective”
- Clascoterone: First Approval
- Clascoterone as a novel treatment for androgenetic alopecia
- Clascoterone in the Treatment of Acne Vulgaris: A Narrative Review
- Real-World Experience of Clascoterone Cream 1% in Acne Management: Case Series and Canadian Experience
- Endocrine control of benign prostatic hyperplasia
- Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness
- Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Steroidogenic enzymes in skin.
- Androgenic alopecia may have evolved to protect men from prostate cancer by increasing skin exposure to ultraviolet radiation
- An update on the treatment of female alopecia and the introduction of a potential novel therapy
- Investigational medications in the treatment of alopecia
- Hidradenitis suppurativa
- Avaliação dos efeitos da finasterida sobre o desenvolvimento prostático intrauterino e pós-natal inicial de fêmeas e machos do gerbilo da Mongólia ("Meriones unguiculatus")
- Cosmeceutical Treatments for Androgenetic Alopecia
- Dyslipidemia in patients with androgenetic alopecia. Statins, finasteride or both?
- Hormone-related hair disorders - from clinical needs to new therapeutic perspectives
- Androgenic alopecia--Its characteristics and perspectives
- Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies
- Тіе Modern treatment of androgenetic alopecia
- The Human Sebocyte Culture Model Provides New Insights into Development and Management of Seborrhoea and Acne
- Anti-androgenic and Hair Growth Promoting Activities of Lygodii Spora (Spore of Lygodium japonicum) I. Active Constituents Inhibiting Testosterone 5.ALPHA.-Reductase.
- Contemporary medical therapy for polycystic ovary syndrome
- Dihydrotestosteron und die Rolle der 5α-Reduktasehemmer bei der benignen Prostatahyperplasie
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Hormonal therapy in female pattern hair loss